SCHEMBL30241803

SCHEMBL30241803

COc1ccc(C(C(=O)CN)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 10/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ KCNN4 O15554 1/20 0.47
▸ CES2 O00748 1/20 0.46
▸ CES1 P23141 1/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29679704 0.84 KCNN4 (0.47) KIF11KCNN4MAPK1RECQLKMT2A
SCHEMBL6045338 0.81 KCNN4 (0.55) KIF11KCNH2KCNN4CES2CES1
SCHEMBL2316036 0.80 KCNN4 (0.53) KIF11KCNH2KCNN4CES2CES1
SCHEMBL27639783 0.79 KIF11 (0.51) KIF11KCNH2CES2CES1NPC1
SCHEMBL30990574 0.77 NPC1 (0.52) KIF11KCNN4NPC1RAB9ACA1
SCHEMBL30241793 0.77 KIF11 (0.59) KIF11KCNH2KCNN4NPC1RAB9A
SCHEMBL30241754 0.77 KIF11 (0.59) KIF11KCNH2KCNN4NPC1RAB9A
SCHEMBL17080312 0.77 CES1 (0.58) KIF11KCNN4CES2CES1NPC1
SCHEMBL17833432 0.76 KCNN4 (0.54) KIF11KCNH2KCNN4CES2CES1
SCHEMBL10603215 0.75 KCNN4 (0.49) KIF11KCNH2KCNN4CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059734-A1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS INC. 2024-02-22 — — US disclosed
EP-4218785-A2 MITOCHONDRIA-TARGETING PEPTIDES Stealth BioTherapeutics Inc. (US) 2023-08-02 — — EP disclosed
US-20230146515-A1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS INC. 2023-05-11 — — US disclosed
EP-3723783-B1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS INC (US) 2023-02-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059734-A1 MITOCHONDRIA-TARGETING PEPTIDES HSPE1, TFAM, TNNI3 KIF11 3536/4885KCNH2 3292/4885KCNN4 3760/4885
US-20230146515-A1 MITOCHONDRIA-TARGETING PEPTIDES HSPE1, TFAM, TNNI3 KIF11 3536/4885KCNH2 3292/4885KCNN4 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback